These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 17714704

  • 21. Comparing protein VEGF inhibitors: In vitro biological studies.
    Yu L, Liang XH, Ferrara N.
    Biochem Biophys Res Commun; 2011 May 06; 408(2):276-81. PubMed ID: 21501594
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate.
    Angulo J, Peiró C, Romacho T, Fernández A, Cuevas B, González-Corrochano R, Giménez-Gallego G, de Tejada IS, Sánchez-Ferrer CF, Cuevas P.
    Eur J Pharmacol; 2011 Sep 30; 667(1-3):153-9. PubMed ID: 21703259
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
    Hohman TC.
    Retina; 2009 Jun 30; 29(6 Suppl):S51-3. PubMed ID: 19553804
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 31. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA, Rosenfeld PJ.
    Curr Opin Ophthalmol; 2009 May 20; 20(3):166-74. PubMed ID: 19381089
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of choroidal and retinal endothelial cells: characteristics and response to VEGF isoforms and anti-VEGF treatments.
    Stewart EA, Samaranayake GJ, Browning AC, Hopkinson A, Amoaku WM.
    Exp Eye Res; 2011 Nov 20; 93(5):761-6. PubMed ID: 21970900
    [Abstract] [Full Text] [Related]

  • 38. [Antivasoproliferative agents in ophthalmology].
    Ambresin A, Zografos L, Mantel I.
    Rev Med Suisse; 2010 Jan 13; 6(231):51-4. PubMed ID: 20196434
    [Abstract] [Full Text] [Related]

  • 39. Role of vascular endothelial growth factor in ocular angiogenesis.
    Shams N, Ianchulev T.
    Ophthalmol Clin North Am; 2006 Sep 13; 19(3):335-44. PubMed ID: 16935208
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.